Hyperfine, Inc. announced the promotion of Tom Teisseyre, Ph.D. to chief operating officer. Dr. Teisseyre will oversee product design and development, clinical science, operations, cybersecurity, and technical service. Dr. Teisseyre has served as chief product officer since June 2021 and has extensive prior experience in medical devices and imaging.

He was the head of surgical and implantable devices of Verily Life Science, formerly Google Life Sciences. Tom also previously held program and product positions at Google, Abbott Medical Optics, Proximie, and OptiMedica. He holds patents and has publications on medical imaging, medical image processing, intraoperative imaging, surgical technology, and surgical workflow optimization.

Tom received his Ph.D. in bioengineering from UC Berkeley and UC San Francisco and a B.S. in biomedical engineering from Georgia Institute of Technology. Hyperfine, Inc. also announced that, for personal reasons, Khan Siddiqui, M.D., will transition from full-time to part-time as chief medical officer and chief strategy officer. In this capacity, Dr. Siddiqui will remain a strategic contributor and an active ambassador for the company within the scientific and medical communities and the projects with the Bill & Melinda Gates Foundation.

Tom will be based out of the Hyperfine, Inc.Palo Alto, California office.